Virgile Visentin

Lipolysis is altered in MHC class I zinc‐α₂‐glycoprotein deficient mice

Véronique Rolli, Mirjana Radosavljevic, Valérie Astier et al. · FEBS Letters · 2007 · 123 citations

Rimonabant, a Selective Cannabinoid CB1 Receptor Antagonist, Inhibits Atherosclerosis in LDL Receptor–Deficient Mice

Frédérique Dol-Gleizes, Réjane Paumelle, Virgile Visentin et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2008 · 123 citations

Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment

Julie Minet-Ringuet, Patrick C. Even, Philippe Valet et al. · Molecular Psychiatry · 2007 · 98 citations

Obesity, Metabolic Syndrome, Energy Homeostasis +11

Tyramine Stimulates Glucose Uptake in Insulin-Sensitive Tissues in Vitro and in Vivo via Its Oxidation by Amine Oxidases

Nathalie Morin, Virgile Visentin, Denis Calise et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 58 citations

Inhibition of rat fat cell lipolysis by monoamine oxidase and semicarbazide-sensitive amine oxidase substrates

Virgile Visentin, D. Prévot, Luc Marti et al. · European Journal of Pharmacology · 2003 · 48 citations

Metabolic Syndrome, Biochemistry, Medicine +6